Quick Answer
Ping An Biomedical Co., Ltd. reported Total Revenue of $34.15 million for fiscal year 2025.
Ping An Biomedical Co., Ltd. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $34.15M -61.0% |
$87.62M +6.1% |
$82.56M | — |
| Net Income | -$1.80M -40.3% |
-$1.28M -29.2% |
-$993.9K | — |
| Diluted EPS | -$0.69 -885.7% |
-$0.07 -16.7% |
-$0.06 | — |
| Total Assets | $68.41M +20.3% |
$56.85M | — | — |
| Cash and Equivalents | $164.7K +25.8% |
$130.9K -77.9% |
$591.9K | — |
| Stockholders Equity | $45.24M +729.4% |
-$7.19M -22.7% |
-$5.86M -227.4% |
$4.60M |
| Operating Income | -$14.70M -720913.8% |
-$2.0K -100.3% |
$612.5K | — |
| Gross Profit | $133.4K -97.5% |
$5.42M +27.8% |
$4.24M | — |
| Shares Outstanding | 20.50M +13.9% |
18.00M | — | — |
- Ping An Biomedical Co., Ltd. reported Total Revenue of $34.15 million for fiscal year 2025.
- Ping An Biomedical Co., Ltd. showed a decrease of -61.0% in Total Revenue compared to the prior fiscal year.
- Ping An Biomedical Co., Ltd. reported Net Income of -$1.80 million for fiscal year 2025.
- Ping An Biomedical Co., Ltd. showed a decrease of -40.3% in Net Income compared to the prior fiscal year.
- Ping An Biomedical Co., Ltd. reported Diluted EPS of $0.69 per share (loss) for fiscal year 2025.
- Ping An Biomedical Co., Ltd. showed a decrease of -885.7% in Diluted EPS compared to the prior fiscal year.
- Ping An Biomedical Co., Ltd. reported Total Assets of $68.41 million for fiscal year 2025.
- Ping An Biomedical Co., Ltd. showed an increase of +20.3% in Total Assets compared to the prior fiscal year.
- Ping An Biomedical Co., Ltd. reported Cash and Equivalents of $164.7 thousand for fiscal year 2025.
- Ping An Biomedical Co., Ltd. showed an increase of +25.8% in Cash and Equivalents compared to the prior fiscal year.
- Ping An Biomedical Co., Ltd. reported Stockholders Equity of $45.24 million for fiscal year 2025.
- Ping An Biomedical Co., Ltd. showed an increase of +729.4% in Stockholders Equity compared to the prior fiscal year.
- Ping An Biomedical Co., Ltd. reported Operating Income of -$14.70 million for fiscal year 2025.
- Ping An Biomedical Co., Ltd. showed a decrease of -720913.8% in Operating Income compared to the prior fiscal year.
- Ping An Biomedical Co., Ltd. reported Gross Profit of $133.4 thousand for fiscal year 2025.
- Ping An Biomedical Co., Ltd. showed a decrease of -97.5% in Gross Profit compared to the prior fiscal year.
- Ping An Biomedical Co., Ltd. reported Shares Outstanding of 20.50 million shares for fiscal year 2025.
- Ping An Biomedical Co., Ltd. showed an increase of +13.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: